Not Yet Recruiting
SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular Carcinoma
NCT07749859
- Conditions
- Adenocarcinoma, Advanced Unresectable Hepatocellular Carcinoma, Carcinoma, +9 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Langfang, Hebei, China